Centene Corp.

CNC | NYSE

Price Alert Chart Builder DCF Calculator

$64.98

-$0.13 (-0.20%)

At close: Sep 21, 2026, 3:59 PM ET

$64.72

-$0.26 (-0.40%)

Pre-market: Sep 22, 2026, 4:15 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.20%

(1D)

Rating

Updated: Aug 29, 2026

34.1

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $32.1B

1D Range

64.56 65.57

52W Range

31.63 69.63

Valuation (TTM)

PE -6.22

PB 1.42

EV/EBITDA -7.31

Valuation (NTM)

Forward PE 12.36

Forward PEG -0.71

Price Target $68.29

Cash Flow

FCF Yield 27.9%

SBC Adj. FCF Yield 27.4%

SBC Impact -2.0%

Margins

Gross Margin 16.1%

Operating Margin -2.8%

FCF Margin 4.6%

Growth (CAGR)

Revenue 3Y | 5Y 9.4% | 10.3%

Dil EPS 3Y | 5Y -2085.4% | -203.9%

FCF 3Y | 5Y 5.4% | 25.6%

Returns

ROA -6.1%

ROE -24.0%

ROIC -12.9%

Financial Health

Net Cash

$10.95B

Current Ratio 1.15

Interest Coverage -8.33

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segmen...

Sector Healthcare

Industry Medical - Healthcare Plans

Employees 61,100

IPO Date Dec 12, 2001

Website www.centene.com

Fiscal Year January - December

Full Company Profile

Latest News

22 hours ago · zacks.com

Centene (CNC) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2 days ago · marketbeat.com

Centene Reaffirms 2026 EPS Outlook as Medicaid Membership Decline Deepens

Centene NYSE: CNC reaffirmed its 2026 adjusted diluted earnings-per-share guidance of more than $4.80 at the Deutsche Bank Healthcare Summit, with Chief Executive Officer Sarah London saying the company's performance through the first two months of the third quarter was in line with expectations.

3 days ago · zacks.com

Is Centene (CNC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

4 days ago · zacks.com

Best Growth Stocks to Buy for September 18th

SNDR, NESR and CNC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 18th, 2026.

4 days ago · zacks.com

Can Centene Sustain Its Turnaround Amid Membership Pressure?

CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.

5 days ago · seekingalpha.com

Centene Corporation (CNC) Presents at Deutsche Bank 2026 Healthcare Summit Transcript

5 days ago · zacks.com

Oscar Health vs. Centene: Which ACA Insurer Is the Better Buy?

Centene's diversified market presence, cash generation and recent share gains give it an edge over Oscar Health as ACA insurers target long-term growth.